Investigators: Bernard Lerer, MD; Osnat Ashur-Fabian, PhD
Market NeedHigh-grade serous (HGS) ovarian cancer is the most lethal gynecologic cancer with a global market size valued at >$1B in 2016. It is expected CAGR of 23.7% at least until 2022, with the U.S. at the forefront. The rising ...
1586128467.png)